---
title: "Download Now: Diagnostic Stewardship for Multiplex Respiratory Testing"
description: Empowering Diagnostic Stewardship in the Post Pandemic World
---

[![Logo_Diasorin_horizontal-1](https://info.diasorin.com/hs-fs/hubfs/Logo_Diasorin_horizontal-1.png?width=224&height=88&name=Logo_Diasorin_horizontal-1.png "Logo_Diasorin_horizontal-1")](https://www.diasorin.com/?hsLang=en)

![Logo_Diasorin_horizontal-1](https://info.diasorin.com/hs-fs/hubfs/Logo_Diasorin_horizontal-1.png?width=188&height=74&name=Logo_Diasorin_horizontal-1.png "Logo_Diasorin_horizontal-1")

![WHITE PAPERS](https://info.diasorin.com/hs-fs/hubfs/WHITE%20PAPERS.png?width=150&height=50&name=WHITE%20PAPERS.png "WHITE PAPERS")

### Diagnostic Stewardship for Multiplex Respiratory Testing: Flexibility is the Name of the Game

Unlock insights with our white paper.

This study examined the rates and frequencies of respiratory pathogen detection among patients of different age groups during the respiratory disease season of 2022-23. It highlights the need for flexible diagnostic testing based on factors like seasonal trends, patient demographics, and reasonable costs while maintaining diagnostic stewardship.

 Fill out the form to get your copy of the white paper.

### Download the White Paper

[![diasorin-logo-1-2](https://info.diasorin.com/hs-fs/hubfs/diasorin-logo-1-2.png?width=130&height=36&name=diasorin-logo-1-2.png "diasorin-logo-1-2")](https://us.diasorin.com/en)

 

**Follow us**

<https://www.linkedin.com/company/diasorin/>.  <https://www.facebook.com/diasorin>

**Group**  
[Company](https://us.diasorin.com/en/company)  
[Sustainability](https://us.diasorin.com/en/sustainability)  
[Investors](https://us.diasorin.com/en/investors)  
[Careers](https://us.diasorin.com/en/careers)  
[Newsroom](https://us.diasorin.com/en/newsroom)

**Our Solutions**  
[Immunodiagnostics](https://us.diasorin.com/en/immunodiagnostics)  
[Molecular Diagnostics](https://us.diasorin.com/en/molecular-diagnostics)  
[Luminex LTG](https://us.diasorin.com/en/licensed-technologies)

**Useful Links**  
[Contact us](https://us.diasorin.com/en/contact-us)  
[Diasorin worldwide](https://us.diasorin.com/en/company/diasorin-worldwide)  
[Immuno products Catalog](https://catalog.diasorin.com/en/disclaimer)  
[My Luminex](https://luminexcorp.my.site.com/CustomerCenter/s/login/?ec=302&startURL=/CustomerCenter/s/)  
[Service and support](https://us.diasorin.com/en/service-support)

**Informatives**  
[Legal notice](https://us.diasorin.com/en/legal-notices)  
[Privacy policy](https://us.diasorin.com/en/diasorin-global-privacy-policy)  
[Modern slavery statement](https://us.diasorin.com/sites/default/files/2023-06/2022_modern_slavery_statement_0.pdf)  
[Accessibility](https://int.diasorin.com/en/accessibility)

**Document Repository**  
Diasorin Immuno and Molecular product documentation[![Dialog](https://info.diasorin.com/hs-fs/hubfs/Screenshot%202023-12-12%20at%2011.43.13%20AM.png?width=135&height=45&name=Screenshot%202023-12-12%20at%2011.43.13%20AM.png)](https://assayinfo.diasorin.com/login)

Licensed Technologies and Luminex products<https://us.diasorin.com/en/product-documents-manuals>[![Product documentation](https://info.diasorin.com/hs-fs/hubfs/Screenshot%202023-12-12%20at%2011.43.24%20AM.png?width=221&height=42&name=Screenshot%202023-12-12%20at%2011.43.24%20AM.png)](https://us.diasorin.com/en/product-documents-manuals)

 

 

![](https://googleads.g.doubleclick.net/pagead/viewthroughconversion/926184002/?value=0&guid=ON&script=0) 

![](https://px.ads.linkedin.com/collect/?pid=1322698&fmt=gif)